AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
Scope & Guideline
Connecting Genes to Mental Health: A New Frontier
Introduction
Aims and Scopes
- Genetic and Environmental Influences:
Research emphasizing the interplay between genetic predispositions and environmental factors in the development of neuropsychiatric conditions, utilizing twin studies and family-based analyses. - Polygenic Risk Scores and Their Applications:
Investigation of polygenic risk scores to predict susceptibility to various psychiatric disorders, assessing their utility in clinical settings and for understanding population-level risks. - Molecular Mechanisms of Psychiatric Disorders:
Studies exploring the molecular pathways and genetic variants implicated in psychiatric disorders, including gene expression analysis and epigenetic modifications. - Neurodevelopmental Genetics:
Focus on genetic contributions to neurodevelopmental disorders, examining how genetic variants affect brain structure and function across the lifespan. - Integration of Multi-Omics Data:
Utilization of integrative approaches combining genomics, transcriptomics, and epigenomics to provide comprehensive insights into neuropsychiatric disorders.
Trending and Emerging
- Artificial Intelligence in Psychiatry:
The incorporation of network-based AI methodologies for personalized psychiatry signifies a trend toward leveraging computational techniques to enhance diagnostic and therapeutic strategies. - Gut-Brain Axis Research:
An increasing focus on the influence of gut microbiota on neuropsychiatric outcomes reflects a growing recognition of the gut-brain connection and its implications for mental health. - Transdiagnostic Approaches:
Research addressing genetic and phenotypic overlaps across multiple psychiatric disorders emphasizes a shift towards understanding shared mechanisms rather than isolated conditions. - Impact of Polygenic Risk Scores on Clinical Outcomes:
Emerging studies examining how polygenic risk scores influence treatment responses and clinical outcomes underscore the application of genetics in personalized medicine. - Neuroimaging Genetics:
The integration of neuroimaging data with genetic information to study brain structure and function in relation to psychiatric disorders is gaining prominence, providing deeper insights into the biological underpinnings of mental health.
Declining or Waning
- Historical Perspectives in Psychiatric Genetics:
Fewer publications revisiting historical analyses or classic theories in psychiatric genetics suggest a move away from retrospective examinations toward more contemporary research frameworks. - Single Gene Studies:
A noticeable decline in studies focusing exclusively on single gene associations indicates a broader trend toward polygenic and multi-factorial approaches, reflecting the complexity of psychiatric disorders. - Pharmacogenetics of Antipsychotic Medications:
Research specifically targeting the pharmacogenetics of antipsychotics has diminished, possibly due to a shift in focus toward broader genetic and environmental interactions.
Similar Journals
Noropsikiyatri Arsivi-Archives of Neuropsychiatry
Connecting Minds: The Intersection of Neuroscience and PsychiatryNoropsikiyatri Arsivi-Archives of Neuropsychiatry is a prominent scholarly journal dedicated to advancing knowledge in the fields of neuropsychiatry and mental health. Published by the Turkish Neuropsychiatry Association, this journal aims to disseminate high-quality research that contributes to a deeper understanding of psychiatric disorders, innovative treatment modalities, and interdisciplinary approaches in neuroscience. Based in Turkey, the journal has been in circulation since its inception, with a rich history reflecting its commitment to addressing contemporary issues in mental health care. It is currently indexed under Scopus, with notable rankings in both Psychiatry and Mental Health (Rank #378/567, 33rd Percentile) and General Neuroscience (Rank #97/113, 14th Percentile), highlighting its increasing relevance and impact in the academia. Although it is not currently an open access journal, its contributions remain vital for researchers, professionals, and students who wish to stay abreast of the latest developments and research in neuropsychiatry.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
Pioneering Advances in Biological Psychiatry.WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, a premier academic journal published by TAYLOR & FRANCIS LTD, stands at the forefront of interdisciplinary research in the fields of Biological Psychiatry, Psychiatry, and Mental Health. Based in the United Kingdom, this esteemed journal (ISSN: 1562-2975; E-ISSN: 1814-1412) has become increasingly influential since its inception in 2000, with a remarkable impact factor that reflects its high-quality research contributions. The journal is consistently ranked in the Q1 and Q2 categories across various relevant indices, demonstrating its reputation for excellence within the academic community. With Scopus rankings placing it in the top 20th percentile for Psychiatry and Mental Health, the WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY serves as a vital resource for researchers, professionals, and students seeking to further their understanding of the intricate relationship between biological processes and psychiatric phenomena. Despite being a traditional access journal, it possesses a robust scope that encompasses groundbreaking studies, reviews, and advancements in the understanding of mental health disorders, underlining its importance as a key reference in the advancement of psychiatric science and therapeutic practices.
MOLECULAR PSYCHIATRY
Transforming Understanding of Psychiatric Disorders through Molecular ResearchMOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.
GENES BRAIN AND BEHAVIOR
Unraveling the Genetic Threads of NeuroscienceGENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.
GENOME
Connecting Researchers to the Heart of GenomicsGENOME is a leading peer-reviewed journal published by Canadian Science Publishing, dedicated to advancing the field of genetics, biotechnology, and molecular biology. With a strong commitment to disseminating high-quality research, GENOME has earned a reputable spot in the academic community, boasting a Q2 classification in Biotechnology and Medicine (miscellaneous), and a Q3 rank in Genetics and Molecular Biology for 2023. The journal, identified by its ISSN 0831-2796 and E-ISSN 1480-3321, publishes innovative studies that span from 1987 to 2024, ensuring a rich historical context while addressing contemporary challenges in the field. Researchers and professionals are encouraged to contribute and engage with content that shapes the landscape of genetic research. Although the journal does not currently provide open access, it remains a vital resource for those committed to the exploration of genomic sciences, making it an essential read for both seasoned researchers and students alike.
Translational Psychiatry
Connecting neuroscience and clinical practice for transformative outcomes.Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.
HUMAN GENETICS
Unveiling the complexities of human genetics.HUMAN GENETICS, published by SPRINGER, stands as a cornerstone journal in the field of genetics, offering a wealth of research insights since its inception in 1964. Hailing from Germany, this esteemed journal boasts an impressive Q1 ranking in both Genetics and Clinical Genetics, marking it among the top quartile of journals in these categories for 2023. With a notable Scopus rank of #7 in Clinical Genetics and a percentile ranking of 93, HUMAN GENETICS attracts significant attention from researchers and professionals dedicated to advancing our understanding of genetic influences on human health and disease. Although it does not currently offer Open Access options, the journal provides a critical platform for scholarly communication, aimed at disseminating groundbreaking findings in genetics and biotechnology. As the field evolves, HUMAN GENETICS continues to play an instrumental role in bridging the gap between laboratory research and clinical application, making it an essential resource for students and seasoned researchers alike.
BEHAVIOR GENETICS
Diving into the Genetic Foundations of BehaviorBEHAVIOR GENETICS is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of behavioral genetics through the dissemination of original research and comprehensive reviews. With its foundation dating back to 1970, the journal has established itself as a crucial forum for scientists studying the interplay between genetic factors and behavior, addressing a diverse range of topics from animal behavior to human psychology. Currently, BEHAVIOR GENETICS holds prestigious rankings with a Q1 quartile in Ecology, Evolution, Behavior and Systematics, and Q2 rankings in both Genetics and Clinical Genetics, as of 2023. This positions the journal among the top tier of scholarly publications, with significant impact reflected in its Scopus ranking across various categories. Researchers, professionals, and students can explore valuable insights and opportunities for collaboration in this vibrant field, although it is noteworthy that the journal offers standard access options. As a valuable resource for cutting-edge discoveries, BEHAVIOR GENETICS continues to foster a deeper understanding of the genetic influences on behavior, making it essential reading for anyone invested in behavioral research.
CURRENT OPINION IN GENETICS & DEVELOPMENT
Shaping the future of genetic research.CURRENT OPINION IN GENETICS & DEVELOPMENT is a prestigious journal published by CURRENT BIOLOGY LTD that offers an insightful platform for the latest developments and emerging trends in the fields of genetics and developmental biology. Established in 1991 and set to continue until at least 2024, this journal achieves notable recognition in the academic community with a Q1 classification in both its major categories as of 2023. With a Scopus rank placing it within the top quartile for both genetics and developmental biology, it serves as an essential resource for researchers, professionals, and students seeking to enhance their understanding of genetic mechanisms and developmental processes. While currently not an open-access journal, readers can explore the collection of high-quality articles that contribute to shaping contemporary scientific discourse and fostering innovation within these dynamic fields. For those dedicated to advancing their research and knowledge, CURRENT OPINION IN GENETICS & DEVELOPMENT stands as a vital and influential academic publication.
PSYCHIATRIC GENETICS
Charting the Genetic Landscape of Psychiatric DisordersPSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.